181 related articles for article (PubMed ID: 15760338)
21. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription.
Yavuzer U; Keenan E; Lowings P; Vachtenheim J; Currie G; Goding CR
Oncogene; 1995 Jan; 10(1):123-34. PubMed ID: 7824265
[TBL] [Abstract][Full Text] [Related]
22. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
24. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
Li CY; Gao TW; Wang G; Han ZY; Shen Z; Li TH; Liu YF
Br J Dermatol; 2004 Jun; 150(6):1081-90. PubMed ID: 15214892
[TBL] [Abstract][Full Text] [Related]
25. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
26. Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.
Trivedi A; Mehrotra A; Baum CE; Lewis B; Basuroy T; Blomquist T; Trumbly R; Filipp FV; Setaluri V; de la Serna IL
Epigenetics Chromatin; 2020 Mar; 13(1):14. PubMed ID: 32151278
[TBL] [Abstract][Full Text] [Related]
27. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma.
Delfgaauw J; Duschl J; Wellbrock C; Froschauer C; Schartl M; Altschmied J
Gene; 2003 Nov; 320():117-26. PubMed ID: 14597395
[TBL] [Abstract][Full Text] [Related]
28. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
29. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
[TBL] [Abstract][Full Text] [Related]
30. Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene.
Fuse N; Yasumoto K; Suzuki H; Takahashi K; Shibahara S
Biochem Biophys Res Commun; 1996 Feb; 219(3):702-7. PubMed ID: 8645245
[TBL] [Abstract][Full Text] [Related]
31. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
[TBL] [Abstract][Full Text] [Related]
32. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.
Poser I; Golob M; Buettner R; Bosserhoff AK
Mol Cell Biol; 2003 Apr; 23(8):2991-8. PubMed ID: 12665595
[TBL] [Abstract][Full Text] [Related]
34. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
Watanabe A; Takeda K; Ploplis B; Tachibana M
Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
[TBL] [Abstract][Full Text] [Related]
35. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
Bosserhoff AK; Echtenacher B; Hein R; Buettner R
Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
Jachimczak P; Apfel R; Bosserhoff AK; Fabel K; Hau P; Tschertner I; Wise P; Schlingensiepen KH; Schuler-Thurner B; Bogdahn U
Int J Cancer; 2005 Jan; 113(1):88-92. PubMed ID: 15386421
[TBL] [Abstract][Full Text] [Related]
37. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
Kamaraju AK; Bertolotto C; Chebath J; Revel M
J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
[TBL] [Abstract][Full Text] [Related]
38. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.
Widlund HR; Fisher DE
Oncogene; 2003 May; 22(20):3035-41. PubMed ID: 12789278
[TBL] [Abstract][Full Text] [Related]
39. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
40. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
